Pfizer Inc. (PFE)
NYSE: PFE · Real-Time Price · USD
26.80
-0.25 (-0.92%)
Mar 9, 2026, 3:42 PM EDT - Market open
Pfizer Revenue
In the year 2025, Pfizer had annual revenue of $62.58B, down -1.65%. Pfizer had revenue of $17.56B in the quarter ending December 31, 2025, a decrease of -1.16%.
Revenue (ttm)
$62.58B
Revenue Growth
-1.65%
P/S Ratio
2.42
Revenue / Employee
$834,387
Employees
75,000
Market Cap
152.39B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 62.58B | -1.05B | -1.65% |
| Dec 31, 2024 | 63.63B | 4.07B | 6.84% |
| Dec 31, 2023 | 59.55B | -41.62B | -41.14% |
| Dec 31, 2022 | 101.18B | 19.89B | 24.46% |
| Dec 31, 2021 | 81.29B | 39.64B | 95.16% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Johnson & Johnson | 94.19B |
| Merck & Co. | 65.01B |
| AbbVie | 61.16B |
| AstraZeneca | 58.74B |
| Novartis AG | 56.67B |
| Sanofi | 54.85B |
| Novo Nordisk | 48.59B |
| Bristol-Myers Squibb Company | 48.19B |
PFE News
- 8 hours ago - Pfizer's eczema drug meets main goal in mid-stage trial, plans late-stage study - Reuters
- 8 hours ago - Pfizer's Phase 2 Study of Trispecific Antibody Positive in Moderate to Severe Atopic Dermatitis - Business Wire
- 2 days ago - 5 Relatively Secure And Cheap Dividend Stocks, Yields Up To 8% (March 2026) - Seeking Alpha
- 3 days ago - Wall Street Breakfast Podcast: India To Buy Russian Oil As War Disrupts Supplies - Seeking Alpha
- 3 days ago - China approves Pfizer GLP-1 drug for weight management - Reuters
- 3 days ago - Judge approves Pfizer, SEC settlement tied to insider trading at Cohen hedge fund - Reuters
- 5 days ago - Seven S&P500 Ideal 'Safer' March Dividend Dogs - Seeking Alpha
- 5 days ago - Pfizer's Portfolio Renewal In Progress - High Yields For The Patient - Seeking Alpha